Xin Lang Cai Jing·2025-08-27 06:21Core Viewpoint - COFCO Biotech reported a significant increase in net profit for the first half of 2025, achieving a net profit attributable to shareholders of 107 million, a year-on-year increase of 74.4% [1]. Financial Performance - The company achieved a net profit of 107 million, up 74.4% year-on-year, and a non-recurring net profit of 31.9 million, up 71.5% [1]. - Despite stable production rates and overall sales, sales revenue decreased due to falling product prices, although gross margins for key products improved [1]. - The overall gross margin increased by 1.3 percentage points year-on-year, approaching 8.5%, with specific product contributions noted [2]. Business Strategies - The company implemented several cost-reduction measures, including enhancing procurement and sales integration, optimizing inventory management, and adopting a "slow procurement, fast sales" strategy [1]. - The company is focusing on new product sales, such as flavored syrups and modified starches, to improve overall gross margins [1]. - The enzyme-based production of allulose has received approval from the health authority, providing a first-mover advantage in the domestic market [1]. Business Segment Insights - Fuel ethanol business remains stable with a market demand of 3-3.5 million tons, and the company maintains a high market share [2]. - The starch sugar business is expanding, with a 150,000-ton expansion project nearing completion and expected to start production by the end of September [2]. - The allulose product is positioned as a key growth area, with significant investment in enzyme research and development, and is expected to see increased demand in the beverage and baking sectors [2]. Future Outlook - The company plans to optimize raw material structure and expand market demand to drive growth in the fuel ethanol segment [2]. - The company is also preparing for the construction of a new starch production facility with an investment of nearly 1 billion, expected to start construction in Q4 of this year [2]. - The allulose product is anticipated to gain traction in the market, with potential for unexpected demand growth if it becomes a popular product [2].